drugset / Trial / NCT00053846

Buspirone in Reducing Shortness of Breath in Patients With Cancer

NCT00053846

RandomizedParallel-groupDouble-blindSupportive care

Summary

RATIONALE: Buspirone may be effective in reducing dyspnea (shortness of breath) in patients with cancer who are undergoing chemotherapy. PURPOSE: Randomized clinical trial to study the effectiveness of buspirone in reducing shortness of breath in patients who are undergoing chemotherapy for cancer.

Timeline

Start
2002-11
Primary completion
2010-11
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Buspirone Small molecule 10 mg Oral